Advertisement

Current Bladder Dysfunction Reports

, Volume 13, Issue 4, pp 288–293 | Cite as

Tibial Nerve and Sacral Neuromodulation in the Elderly Patient

  • Ericka Sohlberg
  • Daniel Greenberg
  • Ekene Enemchukwu
Reconstructed Bladder Function and Dysfunction (M Kaufman, Section Editor)
  • 20 Downloads
Part of the following topical collections:
  1. Topical Collection on Reconstructed Bladder Function & Dysfunction

Abstract

Purpose of Review

This article aims to review sacral and tibial neuromodulation outcomes in elderly patients. Safety and efficacy of these two neuromodulatory treatments for both urinary and fecal indications are addressed.

Recent Findings

Recent data assessing sacral neuromodulation (SNM) for refractory overactive bladder and urge urinary incontinence (UUI) demonstrates that older patients have similar outcomes and complication rates when compared to the general population. For both urinary and fecal indications, SNM has been shown to significantly increase quality of life in older patients. Age has additionally not been a factor affecting tibial nerve stimulation outcomes.

Summary

Limited data specifically addresses use of tibial and sacral neuromodulation in elderly patients. Available studies suggest that both treatment options are safe and effective in the older population for urinary and fecal indications, although further study is necessary.

Keywords

Percutaneous tibial nerve stimulation Sacral nerve stimulation Sacral neuromodulation Elderly Overactive bladder Urgency urinary incontinence Fecal incontinence 

Notes

Compliance with Ethical Standards

Conflict of interest

Ericka Sohlberg, Daniel Greenberg, and Ekene Enemchukwu declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Gorina Y, Schappert S, Bercovitz A, Elgaddal N, Kramarow E. Prevalence of incontinence among older adults. Vital Health Stat 3. 2014;(36):1–33.Google Scholar
  2. 2.
    Morris AR, Ho MT, Lapsley H, Walsh J, Gonski P, Moore KH. Costs of managing urinary and faecal incontinence in a sub-acute care facility: a “bottom-up” approach. Neurourol Urodyn. 2005;24:56–62.  https://doi.org/10.1002/nau.20079.CrossRefPubMedGoogle Scholar
  3. 3.
    Kalisch Ellett LM, Pratt NL, Ramsay EN, Barratt JD, Roughead EE. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. J Am Geriatr Soc. 2014;62:1916–22.  https://doi.org/10.1111/jgs.13054.CrossRefPubMedGoogle Scholar
  4. 4.
    • Vetrano DL, La Carpia D, Grande G, et al. Anticholinergic medication burden and 5-year risk of hospitalization and death in nursing home elderly residents with coronary artery disease. J Am Med Dir Assoc. 2016.  https://doi.org/10.1016/j.jamda.2016.07.012. This study used an objective measurement tool to evaluate anticholinergic burden in a large sample of nursing home residents, showing that anticholinergics increased risk of hospitalization and all—cause mortality.
  5. 5.
    Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32:11–8.  https://doi.org/10.1016/j.ucl.2004.09.004.CrossRefPubMedGoogle Scholar
  6. 6.
    Gourcerol G, Vitton V, Leroi AM, Michot F, Abysique A, Bouvier M. How sacral nerve stimulation works in patients with faecal incontinence. Color Dis. 2011;13:e203–11.  https://doi.org/10.1111/j.1463-1318.2011.02623.x.CrossRefGoogle Scholar
  7. 7.
    Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183:1438–43.  https://doi.org/10.1016/j.juro.2009.12.036.CrossRefPubMedGoogle Scholar
  8. 8.
    Yoong W, Ridout AE, Damodaram M, Dadswell R. Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: outcomes following a shortened 6-week protocol. BJU Int. 2010;106:1673–6.  https://doi.org/10.1111/j.1464-410X.2010.09461.x.CrossRefPubMedGoogle Scholar
  9. 9.
    Hotouras A, Murphy J, Walsh U, Allison M, Curry A, Williams NS, et al. Outcome of percutaneous tibial nerve stimulation (PTNS) for fecal incontinence: a prospective cohort study. Ann Surg. 2014;259:939–43.  https://doi.org/10.1097/SLA.0b013e3182a6266c.CrossRefPubMedGoogle Scholar
  10. 10.
    • Thin NN, Taylor SJC, Bremner SA, Emmanuel AV, Hounsome N, Williams NS, et al. Randomized clinical trial of sacral versus percutaneous tibial nerve stimulation in patients with faecal incontinence. Br J Surg. 2015.  https://doi.org/10.1002/bjs.9695 This RCT compared the efficacy of two modalities of neuromodulation for FI.
  11. 11.
    • Amundsen CL, Webster GD, Walter A, Amundsen. Sacral neuromodulation in an older, urge-incontinent population. Am J Obstet Gynecol. 2002.  https://doi.org/10.1067/mob.2002.130004 This retrospective case series determined success rates of SNM for refractory urge incontinence in an older population, defined as greater than 55 years of age.
  12. 12.
    • White W, Mobley JI, Doggweiler R, Dobmeyer-Dittrich D, FA K. Sacral nerve stimulation for refractory overactive bladder in the elderly population. J Urol. 2009:182(4):1449–52.  https://doi.org/10.1016/j.juro.2009.06.049. This prospective longitudinal study determined success and complication rates of SNM for refractory OAB in an elderly population of females greater than 70 years of age.
  13. 13.
    Edlund C, Dijkema HE, Hassouna MM, Van Kerrebroeck PEV, Peeker R, Van Den Hombergh U, et al. Sacral nerve stimulation for refractory urge symptoms in elderly patients. Scand J Urol Nephrol. 2004;38:131–5.  https://doi.org/10.1080/00365590310022680.CrossRefPubMedGoogle Scholar
  14. 14.
    • Peters KM, Killinger KA, Gilleran J, Boura JA. Does patient age impact outcomes of neuromodulation? Neurourol Urodyn. 2012.  https://doi.org/10.1002/nau. This prospective study of 328 age-stratified OAB patients undergoing staged SNM placement showed no difference in efficacy or complications between age groups.
  15. 15.
    • Angioli R, Montera R, Plotti F, Aloisi A, Montone E, Zullo MA. Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up. Int Urogynecol J. 2013.  https://doi.org/10.1007/s00192-012-1928-3. This prospective study compared outcomes of SNM for UUI in an elderly population of females greater than 65 years of age.
  16. 16.
    Amundsen CL, Romero AA, Jamison MG, Webster GD. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology. 2005;66:746–50.  https://doi.org/10.1016/j.urology.2005.04.031.CrossRefPubMedGoogle Scholar
  17. 17.
    Leong RK, SGG DW, Nieman FHM, De Bie RA, Van Kerrebroeck PEV. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy. Neurourol Urodyn. 2011.  https://doi.org/10.1002/nau.20979.
  18. 18.
    Scheepens WA, Jongen MMGJ, Nieman FHM, De Bie RA, Weil EHJ, Van Kerrebroeck PEV. Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction. Urology. 2002;60:598–602.  https://doi.org/10.1016/S0090-4295(02)01841-1.CrossRefPubMedGoogle Scholar
  19. 19.
    Gross C, Habli M, Lindsell C, South M. Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis. Female Pelvic Med Reconstr Surg. 2010;16:249–53.  https://doi.org/10.1097/SPV.0b013e3181df9b3f.CrossRefPubMedGoogle Scholar
  20. 20.
    Comiter CV. Sacral nerve stimulation to treat nonobstructive urinary retention in women. Curr Urol Rep. 2008;9:405–11.  https://doi.org/10.1007/s11934-008-0069-1.CrossRefPubMedGoogle Scholar
  21. 21.
    Kessler TM, Fowler CJ. Sacral neuromodulation for urinary retention. Nat Clin Pract Urol. 2008;5:657–66.  https://doi.org/10.1038/ncpuro1251.CrossRefPubMedGoogle Scholar
  22. 22.
    Goh M, Diokno AC. Sacral Neuromodulation for nonobstructive urinary retention-is success predictable? J Urol. 2007;178:197–9.  https://doi.org/10.1016/j.juro.2007.03.058.CrossRefPubMedGoogle Scholar
  23. 23.
    Matzel KE. Sacral nerve stimulation for faecal incontinence: its role in the treatment algorithm. Color Dis. 2011;13:10–4.  https://doi.org/10.1111/j.1463-1318.2010.02519.x.CrossRefGoogle Scholar
  24. 24.
    Tjandra JJ, Lim JF, Matzel K. Sacral nerve stimulation: an emerging treatment for faecal incontinence. ANZ J Surg. 2004;74:1098–106.  https://doi.org/10.1111/j.1445-1433.2004.03259.x.CrossRefPubMedGoogle Scholar
  25. 25.
    • George AT, Kalmar K, Goncalves J, Nicholls RJ, Vaizey CJ. Sacral nerve stimulation in the elderly. Colorectal Dis. 2012.  https://doi.org/10.1111/j.1463-1318.2011.02568.x. This publication is the only study on SNS treatment for FI exclusively focused on elderly populations, defined as greater than 65 years of age.
  26. 26.
    Roos AM, Sultan AH, Thakar R. St. Mark’s incontinence score for assessment of anal incontinence following obstetric anal sphincter injuries (OASIS). Int Urogynecol J. 2009;20:407–10.  https://doi.org/10.1007/s00192-008-0784-7.CrossRefGoogle Scholar
  27. 27.
    Maeda Y, Norton C, Lundby L, Buntzen S, Laurberg S. Predictors of the outcome of percutaneous nerve evaluation for faecal incontinence. Br J Surg. 2010;97:1096–102.CrossRefGoogle Scholar
  28. 28.
    Dudding TC, Parés D, Vaizey CJ, Kamm MA. Predictive factors for successful sacral nerve stimulation in the treatment of faecal incontinence: a 10-year cohort analysis. Colorectal Dis. 2008;10:249–56.  https://doi.org/10.1111/j.1463-1318.2007.01319.x.CrossRefPubMedGoogle Scholar
  29. 29.
    Govaert B, Melenhorst J, Nieman FHM, Bols EMJ, Van Gemert WG, Baeten CG. Factors associated with percutaneous nerve evaluation and permanent sacral nerve modulation outcome in patients with fecal incontinence. Dis Colon Rectum. 2009;52:1688–94.  https://doi.org/10.1007/DCR.0b013e3181b55595.CrossRefPubMedGoogle Scholar
  30. 30.
    Roy A-L, Gourcerol G, Menard J-F, Michot F, Leroi A-M, Bridoux V. Predictive factors for successful sacral nerve stimulation in the treatment of fecal incontinence: lessons from a comprehensive treatment assessment. Dis Colon Rectum. 2014;57:772–80.  https://doi.org/10.1097/DCR.0000000000000115.CrossRefPubMedGoogle Scholar
  31. 31.
    • Altomare DF, Giuratrabocchetta S, Knowles CH, Duyos AM, Robert-Yap J, Matzel KE. Long-term outcomes of sacral nerve stimulation for faecal incontinence. Br J Surg. 2015.  https://doi.org/10.1002/bjs.9740. This study provided long-term outcome results of SNS for FI.
  32. 32.
    Wexner SD, Hull T, Edden Y, Coller JA, Devroede G, McCallum R, et al. Infection rates in a large investigational trial of sacral nerve stimulation for fecal incontinence. J Gastrointest Surg. 2010;14:1081–9.  https://doi.org/10.1007/s11605-010-1177-z.CrossRefPubMedGoogle Scholar
  33. 33.
    • Damon H, Barth X, Roman S, Mion F. Sacral nerve stimulation for fecal incontinence improves symptoms, quality of life and patients’ satisfaction: Results of a monocentric series of 119 patients. Int J Colorectal Dis. 2013.  https://doi.org/10.1007/s00384-012-1558-8. This retrospective review showed that older patients experienced greater improvement in quality of life with SNS treatment.
  34. 34.
    Moossdorff-Steinhauser HFA, Berghmans B. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review. Neurourol Urodyn. 2013;32:206–14.  https://doi.org/10.1002/nau.22296.CrossRefPubMedGoogle Scholar
  35. 35.
    Burton C, Sajja A, Latthe P. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn. 2012;31:1206–16.  https://doi.org/10.1002/nau.CrossRefPubMedGoogle Scholar
  36. 36.
    • Schneider MP, Gross T, Bachmann LM, et al. Tibial nerve stimulation for treating neurogenic lower urinary tract dysfunction: a systematic review. Eur Urol. 2015.  https://doi.org/10.1016/j.eururo.2015.07.001. This review compared efficacy of acute and chronic TNS for neurogenic LUTS.
  37. 37.
    Horrocks EJ, Thin N, Thaha MA, Taylor SJC, Norton C, Knowles CH. Systematic review of tibial nerve stimulation to treat faecal incontinence. Br J Surg. 2014;101:457–68.  https://doi.org/10.1002/bjs.9391.CrossRefPubMedGoogle Scholar
  38. 38.
    • Edenfield A, Amundsen C, Wu J, Levin P, Siddiqui N. Posterior tibial nerve stimulation for the treatment of fecal incontinence: a systematic evidence review. Obstet Gynecol Surv. 2015;70:329–41. This systematic review studied the efficacy of PTNS for FI. The majority of the studies reviewed reported statistically significant improvement after therapy. CrossRefGoogle Scholar
  39. 39.
    George AT, Kalmar K, Sala S, Kopanakis K, Panarese A, Dudding TC, et al. Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence. Br J Surg. 2013;100:330–8.  https://doi.org/10.1002/bjs.9000.CrossRefPubMedGoogle Scholar
  40. 40.
    • Booth J, Hagen S, McClurg D, Norton C, MacInnes C, Collins B, et al. A feasibility study of transcutaneous posterior tibial nerve stimulation for bladder and bowel dysfunction in elderly adults in residential care. J Am Med Dir Assoc. 2013.  https://doi.org/10.1016/j.jamda.2012.10.021. This randomized controlled trial compared outcomes of TTNS compared to placebo in elderly patients treated for both bowel and bladder dysfunction.
  41. 41.
    Zinkgraf K, Quinn AO, Ketterhagen D, Kreuziger B, Stevenson K. Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population. Urol Nurs. 2009;29(1):30–4.Google Scholar
  42. 42.
    • Horrocks E, Chadi S, Stevens N, Wexner S, Knowles C. Factors associated with efficacy of percutaneous tibial nerve stimulation for fecal incontinence, based on post-hoc analysis of data from a randomized trial. Clin Gastroenterol Hepatol. 2017;15:1915–21. Post-hoc analysis of CONFIDeNT Trial showed age was not a predictor of success when using PTNS for FI. CrossRefGoogle Scholar
  43. 43.
    Van Balken MR, Vergunst H, Bemelmans BLH. Prognostic factors for successful percutaneous tibial nerve stimulation. Eur Urol. 2006;49:360–5.  https://doi.org/10.1016/j.eururo.2005.10.019.CrossRefPubMedGoogle Scholar
  44. 44.
    Griebling TL. Sacral nerve stimulation in the elderly. Int Urogynecol J. 2010;21:485–9.  https://doi.org/10.1007/s00192-010-1278-y.CrossRefGoogle Scholar
  45. 45.
    Aboseif SR, Kim DH, Rieder JM, Rhee EY, Menefee SA, Kaswick JR, et al. Sacral Neuromodulation: cost considerations and clinical benefits. Urology. 2007;70:1069–73.  https://doi.org/10.1016/j.urology.2007.07.073.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Ericka Sohlberg
    • 1
  • Daniel Greenberg
    • 1
  • Ekene Enemchukwu
    • 1
  1. 1.Department of UrologyStanford UniversityStanfordUSA

Personalised recommendations